BOLT: Bolt Biotherapeutics, Inc. Stock

by  •  • Comments Off on BOLT: Bolt Biotherapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 42.32
Enterprise Value ($M) 31.51
Book Value ($M) 112.74
Book Value / Share 2.96
Price / Book 0.38
NCAV ($M) 58.66
NCAV / Share 1.54
Price / NCAV 0.72

Profitability (mra)
Return on Invested Capital (ROIC) -0.52
Return on Assets (ROA) -0.34
Return on Equity (ROE) -0.44

Liquidity (mrq)
Quick Ratio 5.17
Current Ratio 5.17

Balance Sheet (mrq) ($M)
Current Assets 105.71
Assets 159.78
Liabilities 47.04
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.88
Operating Income -76.20
Net Income -69.20

Cash Flow Statement (mra) ($M)
Cash From Operations -69.53
Cash from Investing 71.04
Cash from Financing 0.25

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Citadel Advisors Llc 6.50
02-14 13G/A Tang Capital Partners Lp 9.60 33.67
02-13 13G/A Vivo Capital VIII, LLC 5.50
02-12 13D/A Pivotal bioVenture Partners Fund I, L.P. 8.10 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 3,001 122,267 2.45
2024-04-25 87 13,036 0.67
2024-04-24 33,241 154,904 21.46
2024-04-23 2,316 17,308 13.38
2024-04-22 5,009 8,948 55.98

(click for more detail)

Similar Companies
BLUE – bluebird bio, Inc. BMEA – Biomea Fusion, Inc.
BMRN – BioMarin Pharmaceutical Inc. BPMC – Blueprint Medicines Corporation
CABA – Cabaletta Bio, Inc.


Financial data and stock pages provided by
Fintel.io